Weekly Recap

YTX-7739 Trials Suspended, ENSURE-2 Study of IMU-838 Initiated, Behavioral Involvement of FTD in ALS

ByNeurologyLive® Staff

January 22nd 2022

Neurology News Network for the week ending January 22, 2022. [WATCH TIME: 4 minutes]

MAO-B Inhibitors Underused in PD, CMS Proposes Decision on Aducanumab Coverage, PREMIUM II Trial of gammaCore Published

ByNeurologyLive® Staff

January 15th 2022

Neurology News Network for the week ending January 15, 2022. [WATCH TIME: 4 minutes]

Awake vs Asleep DBS Impact, Worsened MS Following DMT Discontinuation, Anticoagulation Noninferior to Avoiding it

ByNeurologyLive® Staff

January 8th 2022

Neurology News Network for the week ending January 8, 2022. [WATCH TIME: 3 minutes]

Neurology News Network: Top FDA Approvals of 2021

ByNeurologyLive® Staff

January 1st 2022

Neurology News Network for the week ending January 1, 2022. [WATCH TIME: 4 minutes]

Aducanumab Cost Cut, REFINE-ALS Details Announced, NMOSD Shows Brighter Spotty Lesions Than MOGAD

ByMarco Meglio

December 25th 2021

Neurology News Network for the week ending December 25, 2021.

BXCL501 Study in Alzheimer Begins, Ublituximab BLA Accepted, Sublingual Apomorphine Shows Dominance

ByNeurologyLive® Staff

December 18th 2021

Neurology News Network for the week ending December 18, 2021. [WATCH TIME: 3 minutes]

Perampanel Improves Comorbid Intellectual Disability, Effects of CBTip in PNES, Cenobamate's Impact in Surgically-Refractory Patients

ByNeurologyLive® Staff

December 11th 2021

Neurology News Network for the week ending December 11, 2021. [WATCH TIME: 4 minutes]

Perampanel Improves Comorbid Epilepsy and Migraine, Masupidine to Treat Alzheimer Agitation, Fenfluramine Potential FDA-Approval in LGS

ByNeurologyLive® Staff

December 4th 2021

Neurology News Network for the week ending December 4, 2021. [WATCH TIME: 4 minutes]

ATH-1017 Phase 2 Completes Enrollment, Heart Rate Variability as SUDEP Biomarker, Migraine Not Associated With Insomnia

ByNeurologyLive® Staff

November 27th 2021

Neurology News Network for the week ending November 27, 2021.

AMX0035 Shows Safety in Alzheimer Disease, Outcomes of Urgent Prevention in TIA, FDA Grants IDE to NeuroPace's RNS System

ByNeurologyLive® Staff

November 20th 2021

Neurology News Network for the week ending November 20, 2021.

RBD Shows No Impact Post-DBS, Erenumab Superior to Topiramate, ADORE Phase 3 Trial Begins

ByNeurologyLive® Staff

November 13th 2021

Neurology News Network for the week ending November 13, 2021.

Benefits of Physical Activity in PD, Neonatal Seizures Increased During Rewarming, Cluster Headache Characterized by Creaky Voice

ByNeurologyLive® Staff

November 6th 2021

Neurology News Network for the week ending November 6, 2021.

Ocrelizumab Safety Profile in Elders, Phase 3b CASTING Trial Results, Cannabis Information Sources for MS

ByNeurologyLive® Staff

October 30th 2021

Neurology News Network for the week ending October 30, 2021.

Cenobamate Provides Long-Term Seizure Reduction, Nerivio's Impact in Chronic Migraine, Weekly Episodes Reduced With FT218

ByNeurologyLive® Staff

October 23rd 2021

Neurology News Network for the week ending October 23, 2021. [WATCH TIME: 3 minutes]

Alemtuzumab Treatment Poplation Identified, Siponimod Preserves Retinal Thickness, ATA188 Shows Success in Phase 1

ByNeurologyLive® Staff

October 16th 2021

Neurology News Network for the week ending October 15, 2021. [WATCH TIME: 3 minutes]

XEN1101 Demonstrates Efficacy in Focal Epilepsy, Long-Term Profile of Inebilizumab, Combination of Epilepsy and MS Progress Worse

ByNeurologyLive® Staff

October 9th 2021

Neurology News Network for the week ending October 9, 2021. [WATCH TIME: 3 minutes]

Study of P2B001 in PD Concludes, Verdiperstat Fails in MSA, Fenfluramine sNDA Submitted for LGS

ByMarco Meglio

October 2nd 2021

Neurology News Network for the week of October 2, 2021. [WATCH TIME: 4 minutes]

Noncontact Boxing Improves Movement in Parkinson, Riluzole's Lack of Effect in Spincerebellar Ataxia, Positive Impact of Cannabis in Dystonia

ByNeurologyLive® Staff

September 25th 2021

Neurology News Network for the week ending September 25, 2021. [WATCH TIME: 4 minutes]

AMX0035 NDA Planned, gammaCore Approved to Treat Paroxysmal Hemicrania, Epilepsy Represents Risk Factor for SUD

ByMarco Meglio

September 18th 2021

Neurology News Network for the week ending September 18, 2021.

Joint Mobilization Exercises Improve Systemic Sclerosis Spasticity, Ocrelizumab Long-Term Safety, Antiplatelets Non-Effect on Recurrent ICH

ByNeurologyLive® Staff

September 11th 2021

Neurology News Network for the week ending September 11, 2021.

Salt Substitutes Reduce Stroke Risk, Access to Rehab Disrupted by COVID-19, Headache Infusion Centers Limited

ByNeurologyLive® Staff

September 4th 2021

Neurology News Network for the week ending September 4, 2021.

Fingolimod Preserves MS Cognition, Ravulizumab ALS Trial Discontinued, ADVANCE Results Published

ByNeurologyLive® Staff

August 28th 2021

Neurology News Network for the week ending August 28, 2021.

ACTH Superior to Treat Infantile Spasms, SESI-HRMS Serves as Viable OSA Screening Tool, Myeloid Microvesicles Diagnostic Value in MS

ByNeurologyLive® Staff

August 21st 2021

Neurology News Network for the week ending August 21, 2021.

DTAS Leads to Improved Stroke Outcomes, FDA Approves Avalglucosidase Alfa, No Evidence of Suicidality in ASMs

ByNeurologyLive® Staff

August 14th 2021

Neurology News Network for the week ending August 14, 2021.

Seizure Detection Using Machine Learning, Seroconversion Rate Lower in Anti-CD20 Therapies, Age of Diabetes Onset Correlated With Dementia

ByNeurologyLive® Staff

August 7th 2021

Neurology News Network for the week ending August 7, 2021.

Cenobamate Shows High Retention, Increased Risk of Depression in MS, DAPT Therapy Benefits Moderate Ischemic Stroke

ByNeurologyLive® Staff

July 24th 2021

Neurology News Network for the week ending July 24, 2021.

Starstim Device Granted Breakthrough Designation, Natalizumab Reduces Postpartum Relapse Risk, EFRONT Dementia Study Announced

ByNeurologyLive® Staff

July 17th 2021

Neurology News Network for the week ending July 17, 2021.

Narcolepsy Severity Scale Shows Benefit, Amantadine Improves Daily Living, Pridopidine's Neuroprotective Properties

ByNeurologyLive® Staff

July 10th 2021

Neurology News Network for the week ending July 10, 2021.

Lemborexant Shows Positive Medication Effect, New Comparative Study for CGRPs Announced, Ultra-Early Epilepsy Surgery Effective

ByNeurologyLive® Staff

July 3rd 2021

Neurology News Network for the week ending July 2, 2021.

Eptinezumab Demonstrates Rapid Relief, Zolgensma Improves Motor Function in SMA, RELIEF Study Results

ByNeurologyLive® Staff

June 26th 2021

Neurology News Network for the week ending June 26, 2021.

Weekly Recap

YTX-7739 Trials Suspended, ENSURE-2 Study of IMU-838 Initiated, Behavioral Involvement of FTD in ALS

MAO-B Inhibitors Underused in PD, CMS Proposes Decision on Aducanumab Coverage, PREMIUM II Trial of gammaCore Published

Awake vs Asleep DBS Impact, Worsened MS Following DMT Discontinuation, Anticoagulation Noninferior to Avoiding it

Neurology News Network: Top FDA Approvals of 2021

Aducanumab Cost Cut, REFINE-ALS Details Announced, NMOSD Shows Brighter Spotty Lesions Than MOGAD

BXCL501 Study in Alzheimer Begins, Ublituximab BLA Accepted, Sublingual Apomorphine Shows Dominance

Perampanel Improves Comorbid Intellectual Disability, Effects of CBTip in PNES, Cenobamate's Impact in Surgically-Refractory Patients

Perampanel Improves Comorbid Epilepsy and Migraine, Masupidine to Treat Alzheimer Agitation, Fenfluramine Potential FDA-Approval in LGS

ATH-1017 Phase 2 Completes Enrollment, Heart Rate Variability as SUDEP Biomarker, Migraine Not Associated With Insomnia

AMX0035 Shows Safety in Alzheimer Disease, Outcomes of Urgent Prevention in TIA, FDA Grants IDE to NeuroPace's RNS System

RBD Shows No Impact Post-DBS, Erenumab Superior to Topiramate, ADORE Phase 3 Trial Begins

Benefits of Physical Activity in PD, Neonatal Seizures Increased During Rewarming, Cluster Headache Characterized by Creaky Voice

Ocrelizumab Safety Profile in Elders, Phase 3b CASTING Trial Results, Cannabis Information Sources for MS

Cenobamate Provides Long-Term Seizure Reduction, Nerivio's Impact in Chronic Migraine, Weekly Episodes Reduced With FT218

Alemtuzumab Treatment Poplation Identified, Siponimod Preserves Retinal Thickness, ATA188 Shows Success in Phase 1

XEN1101 Demonstrates Efficacy in Focal Epilepsy, Long-Term Profile of Inebilizumab, Combination of Epilepsy and MS Progress Worse

Study of P2B001 in PD Concludes, Verdiperstat Fails in MSA, Fenfluramine sNDA Submitted for LGS

Noncontact Boxing Improves Movement in Parkinson, Riluzole's Lack of Effect in Spincerebellar Ataxia, Positive Impact of Cannabis in Dystonia

AMX0035 NDA Planned, gammaCore Approved to Treat Paroxysmal Hemicrania, Epilepsy Represents Risk Factor for SUD

Joint Mobilization Exercises Improve Systemic Sclerosis Spasticity, Ocrelizumab Long-Term Safety, Antiplatelets Non-Effect on Recurrent ICH

Salt Substitutes Reduce Stroke Risk, Access to Rehab Disrupted by COVID-19, Headache Infusion Centers Limited

Fingolimod Preserves MS Cognition, Ravulizumab ALS Trial Discontinued, ADVANCE Results Published

ACTH Superior to Treat Infantile Spasms, SESI-HRMS Serves as Viable OSA Screening Tool, Myeloid Microvesicles Diagnostic Value in MS

DTAS Leads to Improved Stroke Outcomes, FDA Approves Avalglucosidase Alfa, No Evidence of Suicidality in ASMs

Seizure Detection Using Machine Learning, Seroconversion Rate Lower in Anti-CD20 Therapies, Age of Diabetes Onset Correlated With Dementia

Cenobamate Shows High Retention, Increased Risk of Depression in MS, DAPT Therapy Benefits Moderate Ischemic Stroke

Starstim Device Granted Breakthrough Designation, Natalizumab Reduces Postpartum Relapse Risk, EFRONT Dementia Study Announced

Narcolepsy Severity Scale Shows Benefit, Amantadine Improves Daily Living, Pridopidine's Neuroprotective Properties

Lemborexant Shows Positive Medication Effect, New Comparative Study for CGRPs Announced, Ultra-Early Epilepsy Surgery Effective

Eptinezumab Demonstrates Rapid Relief, Zolgensma Improves Motor Function in SMA, RELIEF Study Results

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Stem Cells of Secondary Progressive Multiple Sclerosis Drive Increased Proinflammatory T-Cell Activity

Insights Into the Neurobiology of Stuttering From 2025 STARS Conference: Shahriar SheikhBahaei, PhD

Daridorexant Provides Relief for Insomnia in Women During Menopausal Transition

EMA Approves Semaglutide as First GLP-1 RA for Cardiovascular, Stroke-Related Benefits

Optimizing Speech and Movement Therapy to Improve Motor and Nonmotor Symptoms of Parkinson Disease: Cynthia Fox, PhD, CCC-SLP